Endosense Names Nicolas Marsault CFO

Endosense, a Geneva-based medical technology company, has named Nicolas Marsault as its new CFO. Marsault has previously worked in a variety of managerial positions at Merck Serono. He replaces Endosense’s previous chief financial officer, Andrea Buscaglia.

Endosense Raises $36 Million

Endosense, a Geneva, Switzerland-based med-tech company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, has raised $36 million in Series B funding. Edmond de Rothschild Investment Partners led the round, and was joined by Neomed, GIMV, VI Partners, Sectoral Asset Management, Ysios Capital Partners and Initiative Capital Romandie.

PE HUB Community

Join the 12525 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget